Cargando…
SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) that has resulted in the current pandemic. The lack of highly efficacious antiviral drugs that can manage this ongoing global emergency gives urgency to establishing a compr...
Autores principales: | Oh, Soo Jin, Shin, Ok Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999926/ https://www.ncbi.nlm.nih.gov/pubmed/33801464 http://dx.doi.org/10.3390/cells10030530 |
Ejemplares similares
-
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production
por: Chen, Keli, et al.
Publicado: (2020) -
Bovine coronavirus nucleocapsid suppresses IFN-β production by inhibiting RIG-I-like receptors pathway in host cells
por: Xiangbo, Zhang, et al.
Publicado: (2022) -
Differential roles of RIG-I –like receptors in SARS-CoV-2 infection
por: Yang, Duomeng, et al.
Publicado: (2021) -
Differential roles of RIG-I like receptors in SARS-CoV-2 infection
por: Yang, Duo-Meng, et al.
Publicado: (2021) -
Pteropus vampyrus TRIM40 Is an Interferon-Stimulated Gene That Antagonizes RIG-I-like Receptors
por: van Tol, Sarah, et al.
Publicado: (2023)